Real-time enrollment status for this adhd clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06673368 |
| Recruiting Status | Terminated |
| Condition | ADHD |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Neurocentria, Inc. |
| Last Updated on CT.gov | January 15, 2026 (Jan 15, 2026) |
As of March 2, 2026: Clinical trial NCT06673368 is currently terminated participants. This clinical trial study for adhd is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Neurocentria, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06673368 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06673368 was last updated Jan 15, 2026 (January 15, 2026). HelloStudys verifies this status automatically.